Literature DB >> 15958091

Prognostic factors and therapeutic outcome of isolated symptomatic middle cerebral artery stenosis.

N-W Tsai1, H-W Chang, W-N Chang, C-R Huang, T-K Lin, S-D Chen, C-C Lui, K-W Wang, B-C Cheng, P-L Hung, C-S Chang, C-H Lu.   

Abstract

To analyze the prognostic factors and therapeutic outcome of adult patients with isolated symptomatic stenosis of the middle cerebral artery (MCA). Forty-nine patients were retrospectively verified with isolated symptomatic stenosis of the MCA through both magnetic resonance angiogram and transcranial color-coded duplex sonography. Therapeutic outcome at 1 year or more was determined using a modified Barthel index (BI). For the purpose of analysis, the patients were divided into two groups: a good outcome group (BI > or = 12) and a poor outcome group (BI < 12 or recurrent stroke). The association between different therapeutic regimens and the percent free of recurrent stroke after the first event of cerebral infarction was assessed with Kaplan-Meier plots compared by a log-rank test. These patients accounted for 2.8% of all patients with the first event of cerebral infarction during the same period. At follow-up of 1 year or more, 63% had good outcomes whilst the other 37% had poor outcomes. Overall, 26.5% suffered from recurrent strokes during the follow-up period. According to the statistical analysis, the stepwise logistic regression revealed that only the National Institutes of Health Stroke Scale (NIHSS) at the time of admission was independently associated with a poor outcome. Furthermore, Kaplan-Meier analysis showed a significantly higher percentage of patients free of recurrent stroke events amongst those who were treated with warfarin. The NIHSS at the time of admission was a predictor of outcome amongst our patients, and stenosis of the MCA implies the danger of recurrent cerebral events. Our study also demonstrates the efficacy of oral anticoagulants in the secondary prevention in this specific group of patients. Therefore, we look forward to more prospective multicenter investigations in evaluating the efficiency of therapy in the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958091     DOI: 10.1111/j.1468-1331.2005.00995.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

1.  Neurologic symptom severity after a recent noncardioembolic stroke and recurrent vascular risk.

Authors:  Jong-Ho Park; Bruce Ovbiagele
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-03-25       Impact factor: 2.136

2.  Presence of anterior temporal artery associates with good outcome in acute atherosclerotic M1-middle cerebral artery occlusion.

Authors:  Dezhi Liu; Yongkun Li; Zhaorong Shi; Stephen M Davis; Ka Sing Wong; Thomas W Leung; Bernard Yan; Yunyun Xiong; Wen Sun; Gelin Xu; Renliang Zhang; Xinfeng Liu
Journal:  Neuroradiology       Date:  2014-09-09       Impact factor: 2.804

3.  Factors related to progression of middle cerebral artery stenosis determined using transcranial Doppler ultrasonograhy.

Authors:  Hyung-Won Jeon; Jae-Kwan Cha
Journal:  J Thromb Thrombolysis       Date:  2007-06-01       Impact factor: 2.300

4.  Long-term prognosis of symptomatic isolated middle cerebral artery disease in Korean stroke patients.

Authors:  Mi Sun Oh; Kyung-Ho Yu; Min-Kyung Chu; Hyeo-Il Ma; Yun Joong Kim; Joo Yong Kim; Byung-Chul Lee
Journal:  BMC Neurol       Date:  2011-11-04       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.